“Efficacy or Illusion?” Interpreting Null Results in the Rifaximin Trial

IF 33 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-08-20 DOI:10.1016/j.jhep.2025.08.012

Zhihao Lei

引用次数: 0

Abstract

Section snippets

Financial support

The author received no funding for this work.

Authors' contributions

Zhihao Lei — Conceptualization, Investigation, Writing – Original Draft, Writing – Review & Editing.

Declaration of Competing Interest

The author declares no conflicts of interest.Please refer to the accompanying ICMJE disclosure forms for further details.

查看原文本刊更多论文

“功效还是幻觉？”利福昔明试验无效结果的解释

经济支持本文作者未获得任何资助。作者贡献：雷志浩-构思、调查、写作-原稿、写作-审稿、编辑。利益冲突声明作者声明无利益冲突。详情请参阅随附的ICMJE披露表格。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.